Multi-centre, Double-blind, Randomised, Parallel-group, Placebo-controlled, Phase 3 Study of the Efficacy & Safety of Quetiapine Fumarate & Lithium as Monotherapy in Adult Patients With Bipolar Depression for 8 Weeks & Quetiapine in Continuation (Abbreviated)
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2014
At a glance
- Drugs Quetiapine (Primary) ; Lithium
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Registrational; Therapeutic Use
- Acronyms EMBOLDEN-I
- Sponsors AstraZeneca
- 26 Jan 2010 Results were published in the Journal of Clinical Psychiatry.
- 01 Apr 2009 Additional locations Canada, Germany, Poland, Russia reported by ClinicalTrials.gov.
- 01 Apr 2009 End date 1 May 2007 added from ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History